Current Issue Table of Contents: Clinical Lung Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications

Byoung Chul Cho,
Allison Simi,
Joshua Sabari,
Smruthi Vijayaraghavan,
Sheri Moores,
Alexander Spira

Published online: November 10, 2022

p89-97

Open Access

Pregnancy and Pathways to Motherhood in Oncogene-driven Lung Cancer: A Single Institution Experience

Emily A. Simons,
Tejas Patil,
D. Ross Camidge

Published online: November 10, 2022

e55-e59

Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report

Lindsey B. Shantzer,
Sean C. Dougherty,
Fabian Bolte,
...
Ryan D. Gentzler,
Wendy Novicoff,
Richard D. Hall

Published online: November 25, 2022

e60-e64

A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations

John Heymach,
Frans Opdam,
Minal Barve,
...
Behbood Sadrolhefazi,
Josep Serra,
Noboru Yamamoto

Published online: November 10, 2022

e65-e68

Open Access

Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital

Laura Burns,
Chinmay Jani,
Amr Radwan,
...
Mohini Patel,
Geoffrey R. Oxnard,
Umit Tapan

Published online: November 11, 2022

e69-e77

Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer

Kristine N. Kim,
Jonathan Heintz,
Nikhil Yegya-Raman,
...
John Kucharczuk,
Kyle Robinson,
Steven Feigenberg

Published online: December 24, 2022

e78-e86

Timeliness of Lung Cancer Care From the Point of Suspicious Image at an Urban Safety Net Hospital

Noreen Siddiqi,
Gilbert Pan,
Anqi Liu,
...
Kimberley Mak,
Umit Tapan,
Kei Suzuki

Published online: December 24, 2022

e87-e93

Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study

Huiying Li,
Shengnan Zheng,
Yongjuan Lin,
...
Xiangyu Liu,
Xiaoping Qian,
Zhenyu Yin

Published online: December 05, 2022

e94-e104

Open Access

The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study

Chenchen Zhang,
Roger Y. Kim,
Cindy M. McGrath,
...
Christoph T. Hutchinson,
Jennifer J.D. Morrissette,
David M. DiBardino

Published online: December 04, 2022

e105-e112

Editorial Board

Published in issue: March 2023

A2-A4

March 2023

Review

Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications

Original Studies

Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning

Distinct Prognostic Impact of PET Findings Based on Radiological Appearance in Clinical Stage IA Lung Adenocarcinoma

Trends in Stage I Lung Cancer

Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC)

The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation

27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study

Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database Study

Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital

The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer

Pretreatment Platelet Count is a Prognostic Marker in Lung Cancer: A Danish Registry-based Cohort Study

Available Exclusively Online at www.clinical-lung-cancer.com

Pregnancy and Pathways to Motherhood in Oncogene-driven Lung Cancer: A Single Institution Experience

Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibition in Combination With Chemotherapy: A Brief Report

A Phase I, Open-Label, Dose Confirmation, Escalation, and Expansion Trial of BI 1810631 as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations

Implementation Challenges and Disparities in Molecular Testing for Patients With Stage IV NSCLC: Perspectives from an Urban Safety-Net Hospital

Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer

Timeliness of Lung Cancer Care From the Point of Suspicious Image at an Urban Safety Net Hospital

Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study

The Performance of an Extended Next Generation Sequencing Panel Using Endobronchial Ultrasound-Guided Fine Needle Aspiration Samples in Non-Squamous Non-Small Cell Lung Cancer: A Pragmatic Study

Frontmatter

Editorial Board

Table of Contents